DETECT

August 6, 2020

Translational study investigating the role of circulating biomarkers of breast cancer that indicate its potential progression and resistance to therapy.

Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect